Eli Lilly
2,022 hedge funds and large institutions have $182B invested in Eli Lilly in 2021 Q2 according to their latest regulatory filings, with 191 funds opening new positions, 714 increasing their positions, 755 reducing their positions, and 95 closing their positions.
101% more first-time investments, than exits
New positions opened: 191 | Existing positions closed: 95
33% more funds holding in top 10
Funds holding in top 10: 46 → 61 (+15)
23% more capital invested
Capital invested by funds: $148B → $182B (+$34.1B)
4% more funds holding
Funds holding: 1,949 → 2,022 (+73)
0.01% more ownership
Funds ownership: 82.73% → 82.74% (+0.01%)
5% less repeat investments, than reductions
Existing positions increased: 714 | Existing positions reduced: 755
18% less call options, than puts
Call options by funds: $1.41B | Put options by funds: $1.72B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$697M |
| 2 |
BlackRock
New York
|
+$373M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$315M |
| 4 |
AT
AMF Tjänstepension
Stockholm,
Sweden
|
+$211M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$163M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Primecap Management
Pasadena,
California
|
-$285M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$253M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$186M |
| 4 |
Lilly Endowment
Indiananapolis,
Indiana
|
-$181M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$154M |
LLY Hedge Fund Activity: Q2 2021 in Review
2,022 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2021, worth a combined $182B — up 23% from $148B a quarter earlier.
Buyers outnumbered sellers: 191 funds opened new LLY positions and 95 closed out — a net gain of 96 holders — while 714 added to existing stakes and 755 trimmed.
The largest buyer was Jennison Associates, adding an estimated $697M. The largest seller was Primecap Management, cutting an estimated $285M.
- 2,022 institutional investors held Eli Lilly (LLY) as of Q2 2021, up from 1,949 in Q1 2021.
- Funds reported $182B of Eli Lilly stock for Q2 2021, up 23% quarter-over-quarter.
- 191 funds opened new Eli Lilly positions in Q2 2021 and 95 closed out, a net change of +96 holders.
- The largest Eli Lilly buyer in Q2 2021 was Jennison Associates, an estimated $697M added.
- The largest Eli Lilly seller in Q2 2021 was Primecap Management, an estimated $285M sold.
Based on aggregated 13F filings for Q2 2021.